Biosynthesis of mogrosides

US12234464B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12234464-B2
Application numberUS-201917292266-A
CountryUS
Kind codeB2
Filing dateNov 9, 2019
Priority dateNov 9, 2018
Publication dateFeb 25, 2025
Grant dateFeb 25, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are enzymes (e.g., cucurbitadienol synthases (CDS), UDP-glycosyltransferases (UGT), C11 hydroxylases, epoxide hydrolases (EPH), squalene epoxidases, and/or cytochrome P450 reductases), host cells expressing the enzymes, and methods of producing mogrol precursors, mogrol, and/or mogrosides using such host cells.

First claim

Opening claim text (preview).

What is claimed is: 1. A host cell that comprises a heterologous polynucleotide encoding a cucurbitadienol synthase (CDS) enzyme, wherein the heterologous polynucleotide sequence is at least 90% identical to SEQ ID NO: 3 and/or the amino acid sequence of the CDS encoded by the heterologous polynucleotide is at least 90% identical to SEQ ID NO: 43, and wherein the host cell produces 11-hydroxycucurbitadienol, 24-25 epoxy-cucurbitadienol or cucurbitadienol, and wherein the host cell is not a plant cell. 2. The host cell of claim 1 , wherein the CDS comprises a leucine at the amino acid residue corresponding to the amino acid residue at position 123 of SEQ ID NO: 73. 3. The host cell of claim 1 , wherein the host cell further comprises one or more heterologous polynucleotides encoding a UDP-glycosyltransferase (UGT), a C11 hydroxylase, a cytochrome P450 reductase, an epoxide hydrolase (EPH), a lanosterol synthase, and/or a squalene epoxidase. 4. A method of producing 11-hydroxycucurbitadienol, 24-25 epoxy-cucurbitadienol or cucurbitadienol, comprising contacting the host cell of claim 1 with 2-3-oxidosqualene or 2,3; 22,23-diepoxysqualene, thereby producing the 11-hydroxycucurbitadienol, 24-25 epoxy-cucurbitadienol or cucurbitadienol. 5. The method of claim 4 , wherein the method further comprises isolating the 11-hydroxycucurbitadienol, 24-25 epoxy-cucurbitadienol or cucurbitadienol. 6. The host cell of claim 1 , wherein the host cell is a yeast cell or a bacterial cell. 7. The host cell of claim 6 , wherein the host cell is a Saccharomyces cell or a Yarrowia cell. 8. The host cell of claim 6 , wherein the host cell is an E. coli cell. 9. The host cell of claim 1 , wherein the host cell produces at least 10%, 20%, or 30% more 11-hydroxycucurbitadienol, 24-25 epoxy-cucurbitadienol or cucurbitadienol relative to a control, wherein the control is a host cell that expresses S. grosvenorii CDS, encoded by a polynucleotide corresponding to SEQ ID NO: 33. 10. The host cell of claim 1 , wherein the CDS comprises the motif DQGWL (SEQ ID NO: 335). 11. The host cell of claim 10 , wherein the motif DQGWL (SEQ ID NO: 335) is located at residues in the CDS corresponding to residues 479-483 in SEQ ID NO: 73. 12. The host cell of claim 1 , wherein the CDS comprises the motif GHWANDLGGP (SEQ ID NO: 336). 13. The host cell of claim 12 , wherein the motif GHWANDLGGP (SEQ ID NO: 336) is located at residues in the CDS corresponding to residues 117-126 in SEQ ID NO: 73. 14. The host cell of claim 1 , wherein the CDS comprises the motif CWGVCYTYAGW (SEQ ID NO: 337). 15. The host cell of claim 14 , wherein the motif CWGVCYTYAGW (SEQ ID NO: 337) is located at residues in the CDS corresponding to residues 612-622 in SEQ ID NO: 73. 16. The host cell of claim 1 , wherein the amino acid sequence of the CDS comprises SEQ ID NO: 43. 17. The host cell of claim 7 , wherein the host cell is a Saccharomyces cerevisiae cell. 18. The host cell of claim 7 , wherein the host cell is a Yarrowia lipolytica cell. 19. The host cell of claim 1 , wherein the host cell is further modified to downregulate ERG7.

Assignees

Inventors

Classifications

  • Hexosyltransferases (2.4.1) · CPC title

  • Preparation of steroids · CPC title

  • produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins · CPC title

  • Acting on D ring {(carbons 13 and 14 belong to the C ring; degradation of lateral chains C12P33/005)} · CPC title

  • Terpene glycosides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12234464B2 cover?
Provided herein are enzymes (e.g., cucurbitadienol synthases (CDS), UDP-glycosyltransferases (UGT), C11 hydroxylases, epoxide hydrolases (EPH), squalene epoxidases, and/or cytochrome P450 reductases), host cells expressing the enzymes, and methods of producing mogrol precursors, mogrol, and/or mogrosides using such host cells.
Who is the assignee on this patent?
Ginkgo Bioworks Inc
What technology area does this patent fall under?
Primary CPC classification C12Y504/99033. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).